학술논문
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
Document Type
Article
Author
Spencer, A.J.; Morris, S.; Ulaszewska, M.; Powers, C.; Kailath, R.; Bissett, C.; Truby, A.; Thakur, N.; Allen, E.R.; Rudiansyah, I.; Davies, H.; Donnellan, F.R.; Pulido, D.; Gilbert, S.C.; Lambe, T.; Newman, J.; Bailey, D.; Liu, C.; Dejnirattisai, W.; Mongkolsapaya, J.; Screaton, G.; Peacock, T.P.; Barclay, W.S.; Bright, H.; Ren, K.; McTamney, P.
Source
In: eBioMedicine . (eBioMedicine, March 2022, 77)
Subject
Language
English
ISSN
23523964